US-based Sciton has unveiled its hybrid fractional laser (HFL), diVa, for vaginal tissue rejuvenation.

Vaginal health can be affected during childbirth due to excessive stretching of the tissue and the menopause, which causes dryness, thinning and expose the vaginal walls. Sex can also cause damage.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Sciton’s diVa offers a solution that can be customised, such as separate procedures for pre-menopause and woman who has reached menopause.

diVa investigator Johnny Peet said: "With the addition of diVa, we have a new solution to improve self-esteem and quality of life for our patients.

"I am addressing intimate issues such as painful intercourse or dryness with a real solution."

"So many of our patients can benefit from this type of treatment. I am addressing intimate issues such as painful intercourse or dryness with a real solution.

"They are now coming forward, being treated and are ecstatic about the results."

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

diVa is based on Sciton’s Halo dual fractionated laser technology, which enables the device to generate both ablative and non-ablative wavelengths to the same microscopic treatment zone paving the way for customisable procedures.

The first generated laser causes a deep resurface of the vaginal wall layers, resulting in its replacement with new, healthy tissue.

The second laser heats layers of the tissue, resulting in an inflammatory response to foster healthy cellular activity in the skin.

It involves an automated process where physicians use high-precision automation (HPA) technology to insert the strengthened quartz dilator of the device and press the foot switch.

Treatment involving diVa is suggested to be administered three times with a gap of 30 days, coupled with one annual treatment to maintain results.

Users are advised to avoid intercourse for up to 48 hours.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Awarded for Innovation in Remote Hearing Diagnostics , hearX’s Self Test Kit (STK) delivers clinically validated audiometry via smart devices, enabling remote, scalable hearing assessments in homes, clinics and retail. Learn how hearX is redefining hearing care delivery and reducing costs for providers globally.

Discover the Impact